Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.41 |
| ▸ | CLK2 | P49760 | 1/20 | 0.41 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.41 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.41 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.41 |
| ▸ | DYRK1B | Q9Y463 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | HPGD | P15428 | 4/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | NOS2 | P35228 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.37 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22062741 | 0.88 | KDM4E (0.40) | KDM4EHSD17B10MAPTPOLBCSNK1A1 | |
| SCHEMBL824377 | 0.84 | KDM4E (0.47) | KDM4EHSD17B10MAPTPOLBCSNK1A1 | |
| SCHEMBL22062737 | 0.84 | KDM4E (0.39) | KDM4EHSD17B10MAPTPOLBLMNA | |
| SCHEMBL22062742 | 0.84 | KDM4E (0.38) | KDM4EHSD17B10MAPTPOLBCSNK1A1 | |
| SCHEMBL14868036 | 0.83 | KDM4E (0.42) | KDM4EHSD17B10MAPTPOLBCSNK1A1 | |
| SCHEMBL22063066 | 0.83 | SMN1; SMN2 (0.42) | KDM4EHSD17B10MAPTPOLBLMNA | |
| SCHEMBL22063055 | 0.83 | SMN1; SMN2 (0.43) | KDM4EHSD17B10MAPTPOLBLMNA | |
| SCHEMBL22062730 | 0.83 | KDM4E (0.37) | KDM4EHSD17B10MAPTPOLBLMNA | |
| SCHEMBL24495866 | 0.82 | KDM4E (0.41) | KDM4EHSD17B10MAPTPOLBCSNK1A1 | |
| SCHEMBL22062533 | 0.82 | ALDH1A1 (0.44) | KDM4EHSD17B10MAPTPOLBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11708355-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-25 | — | — | US | disclosed |
| US-11708355-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-07-25 | — | — | US | disclosed |
| US-20210032225-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2021-02-04 | — | — | US | disclosed |
| US-20200185620-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-06-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210032225-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, BRD1 | KDM4E 1758/4885HSD17B10 1392/4885MAPT 1300/4885 |
| US-20200185620-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | EMC2, NFE2L2, AOC2 | KDM4E 1152/4885HSD17B10 1542/4885MAPT 2667/4885 |
| US-11708355-B2 | Organic electroluminescent materials and devices | OCIAD1, OCIAD2, BRD1 | KDM4E 1758/4885HSD17B10 1392/4885MAPT 1300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.